Biomolecule with therapeutic tumour action and its use

A technology of biomolecules and anti-tumor drugs, applied in the direction of sugar derivatives, anti-tumor drugs, organic active ingredients, etc., to achieve the effects of overcoming toxic side effects, good stability and high selectivity

Inactive Publication Date: 2004-09-15
TIANJIN SAIER BIOTECH
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The present inventors have carried out in-depth research in order to achieve the above object, and found that a double-stranded RNA molecule (structure shown in Figure 1) with a length of 23 base pairs in a specific order has a clear tumor-inhibiting effect, And the selectivity of its action is high, can overcome the toxic and side effects that quinolines exist to a large extent; Due to the disadvantages of poor stability and weak effect due to easy degradation, its tumor inhibitory effect is significantly higher than that of antisense nucleic acid

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Biomolecule with therapeutic tumour action and its use
  • Biomolecule with therapeutic tumour action and its use
  • Biomolecule with therapeutic tumour action and its use

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

Embodiment 2

Embodiment 3

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention is a biomolecule curing tumours, its character: in a special sequence, it is a dichain RNA molecule with 23 basic groups. Its molecular structure contains adenine nucleotide A, guanosine G, cytidine C and uridine U. Its beneficial effects: 1, obvious effect of prohibiting tumour growth and high selectivity, able to overcome poisonous side effect of quinoline drug; 2, good stability; 3, effect amplification; 4, easy to prepare. It can be used to prepare clinical antitumor drug, where the drug form is any one of water solution injection, liposome soliquoid injection and latex.

Description

technical field The present invention relates to the field of biomedicine, and more specifically, relates to biomolecules capable of treating tumors and their application. Background technique Tumor has become one of the most serious diseases that endanger human health globally. Due to the complexity of the causes of tumors, effective prevention cannot be carried out; at the same time, due to the particularity of tumor growth, it is difficult to diagnose early. Therefore, the treatment of neoplastic diseases mainly depends on clinical treatment. However, most of the current clinical drug treatments do not have obvious selectivity, and they also have obvious toxic side effects on normal cells. Therefore, the development of anti-tumor drugs with low toxicity, high selectivity and high effectiveness is the most urgent task in the field of medical biology today. With the deepening understanding of the molecular mechanism of tumor development, some molecules with higher spec...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/08A61K9/107A61K9/12A61K31/7088A61P35/00C07H21/00
Inventor 汤华李欣
Owner TIANJIN SAIER BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products